Skip to main content

Attovia Therapeutics, Inc.

ATTO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002058707

In the last 90 days, Attovia Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 65 institutions reported holding it in 13F filings for Q3 2026, worth $693.4M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Attovia Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
65
+65 vs. Q2 2026
Shares held
40.5M
+40.5M vs. Q2 2026
Total value
$693.4M
+$693.4M vs. Q2 2026
New holders
65
0 more added
Sold out
0
0 more reduced

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATTO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 65 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutionsQ3 2026: 65 institutions
Value heldQ3 2026: $693.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: $693.4M
Institutions holding ATTO and their total value by quarter
QuarterHoldersValue
Q3 202665$693.4M
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Attovia Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding ATTO in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Advisor Group Holdings, Inc.180$3.12K0.00%+180New
Citigroup Inc1,237$21.2K0.00%+1,237New
Persistent Asset Partners Ltd2,465$42.3K0.01%+2,465New
Allworth Financial LP4,000$68.6K0.00%+4,000New
Vanguard Global Advisers, LLC6,602$113.2K0.00%+6,602New
Aster Capital Management (DIFC) Ltd7,774$133.2K0.05%+7,774New
Diadema Partners LP9,700$166.3K0.06%+9,700New
Soleus Capital Management, L.P.10,000$171.4K0.01%+10,000New
D. E. Shaw & Co., Inc.10,058$172.4K0.00%+10,058New
ExodusPoint Capital Management, LP13,576$232.7K0.00%+13,576New
Landscape Capital Management, L.L.C.14,806$253.8K0.02%+14,806New
Legal & General Group Plc15,000$256.3K0.00%+15,000New
Walleye Capital LLC15,107$258.9K0.00%+15,107New
Jump Financial, LLC16,594$284.4K0.00%+16,594New
Vanguard Portfolio Management LLC20,495$351.3K0.00%+20,495New
Schonfeld Strategic Advisors LLC22,243$381.2K0.00%+22,243New
State Street Corp24,250$415.6K0.00%+24,250New
HRT Financial LP30,868$529.0K0.00%+30,868New
Morgan Stanley38,451$659.0K0.00%+38,451New
Northern Trust Corp39,287$673.4K0.00%+39,287New
LMR Partners LLP40,000$685.6K0.01%+40,000New
Squarepoint Ops LLC42,725$732.3K0.00%+42,725New
Two Sigma Investments, LP54,828$939.8K0.00%+54,828New
Seven Grand Managers, LLC90,000$1.54M0.06%+90,000New
Ghisallo Capital Management LLC105,000$1.80M0.03%+105,000New
Vanguard Fiduciary Trust Co109,177$1.87M0.00%+109,177New
Charles Schwab Investment Management Inc114,952$1.97M0.00%+114,952New
Burkehill Global Management, LP120,000$2.06M0.09%+120,000New
Freestone Grove Partners LP120,000$2.06M0.02%+120,000New
Cantor Fitzgerald, L. P.133,959$2.30M0.04%+133,959New
StemPoint Capital LP138,200$2.37M0.42%+138,200New
Point72 Asset Management, L.P.180,664$3.10M0.00%+180,664New
Jones Hill Capital LP182,295$3.12M0.53%+182,295New
UBS Group AG183,751$3.15M0.00%+183,751New
Boxer Capital Management, LLC200,000$3.43M0.30%+200,000New
Kalehua Capital Management LLC200,000$3.43M2.59%+200,000New
Geode Capital Management, LLC206,176$3.54M0.00%+206,176New
Braidwell LP225,000$3.86M0.16%+225,000New
Spruce Street Capital LP228,295$3.91M0.62%+228,295New
BlackRock, Inc.265,397$4.55M0.00%+265,397New
Vivo Capital, LLC300,000$5.14M0.57%+300,000New
FMR LLC323,669$5.55M0.00%+323,669New
Blackstone Group Inc.339,920$5.83M0.02%+339,920New
Logos Global Management LP391,426$6.71M0.39%+391,426New
Integral Health Asset Management, LLC450,000$7.71M0.47%+450,000New
Balyasny Asset Management LLC459,297$7.87M0.02%+459,297New
Citadel Advisors LLC466,773$8.00M0.00%+466,773New
Millennium Management LLC476,261$8.16M0.01%+476,261New
Adage Capital Partners GP, L.L.C.500,000$8.57M0.01%+500,000New
Nantahala Capital Management, LLC561,180$9.62M0.54%+561,180New
Woodline Partners LP686,746$11.8M0.04%+686,746New
Federated Hermes, Inc.700,000$12.0M0.02%+700,000New
Vanguard Capital Management LLC782,012$13.4M0.00%+782,012New
Marshall Wace, LLP898,980$15.4M0.01%+898,980New
Janus Henderson Group PLC1,000,000$17.1M0.01%+1,000,000New
Sanofi1,082,855$18.6M2.95%+1,082,855New
Commodore Capital LP1,160,000$19.9M1.54%+1,160,000New
Redmile Group, LLC1,163,587$19.9M1.46%+1,163,587New
Cormorant Asset Management, LP1,788,815$30.7M2.06%+1,788,815New
Nextech Invest, Ltd.1,835,139$31.5M1.41%+1,835,139New
EcoR1 Capital, LLC2,024,010$34.7M1.71%+2,024,010New
Deep Track Capital, LP3,207,138$55.0M0.93%+3,207,138New
venBio Partners LLC4,181,366$71.7M14.45%+4,181,366New
Goldman Sachs Group Inc5,391,772$92.4M0.01%+5,391,772New
Frazier Life Sciences Management, L.P.7,046,271$120.8M3.00%+7,046,271New